CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2016	Sep. 26, 2015
Cash flows from operating activities:
Consolidated net income	$ 359,765	$ 341,078
Adjustments to reconcile consolidated net income to net cash provided by operations:
Depreciation and amortization	121,516	117,854
Amortization of stock-based compensation	29,783	33,783
Equity in earnings of affiliated companies	(5,394)	(4,890)
Deferred income taxes	30,191	26,881
Gain on Sale of Investments	0	(2,008)
Excess tax benefits from stock-based compensation arrangements	(4,953)	(5,863)
Other	4,464	8,057
Change in assets and liabilities, net of effects of acquired businesses:
Accounts receivable	335,455	1,056,282
Inventories	(117,674)	(44,890)
Accounts payable	(513,365)	(1,318,702)
Accrued expenses	(102,915)	(72,728)
Other assets and liabilities	(1,121)	(23,910)
Net cash provided by operating activities	135,752	110,944
Cash flows from investing activities:
Cash consideration paid for acquired businesses	(68,946)	(512,910)
Acquisition of property, plant, and equipment	(126,341)	(113,056)
Other	(12,000)	2,008
Net cash used for investing activities	(207,287)	(623,958)
Cash flows from financing activities:
Change in short-term and other borrowings	31,941	(4,069)
Proceeds from long-term bank borrowings, net	320,000	238,700
Net proceeds from note offering	0	688,162
Redemption of notes	0	(254,313)
Proceeds from exercise of stock options	16,686	14,722
Excess tax benefits from stock-based compensation arrangements	4,953	5,863
Repurchases of common stock	(167,178)	(206,601)
Other	(3,000)	(5,831)
Net cash provided by financing activities	203,402	476,633
Effect of exchange rate changes on cash	(20,542)	(27,230)
Net increase (decrease) in cash and cash equivalents	111,325	(63,611)
Cash and cash equivalents at beginning of period	273,090	400,355
Cash and cash equivalents at end of period	$ 384,415	$ 336,744